Table 7 Additional tests and costs with HC2 and Cobas versus Aptima until the first colposcopy
From: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
Diagnostic tests* after the first HPV test, n = | Costs, € | Additional tests* versus Aptima, n = | Additional costs versus Aptima, € | |
|---|---|---|---|---|
Aptima® HPV | 786,195 | 10,626,532.78 € | – | − |
Hybrid Capture® 2 | 989,993 | 392,078,694.14 €** | 203,798 | 381,452,161.36 € |
Cobas® 4800 | 972,460 | 13,144,973.31 € | 186,265 | 2,518,440.53 € |